C-REACTIVE PROTEIN AND ANTIBODIES TO HELICOBACTER PYLORI IN THE PATIENTS WITH ISCHEMIC HEART DISEASE
https://doi.org/10.15789/1563-0625-2007-4-5-523-526
Abstract
Abstract. Levels of C-reactive protein and immunoglobulin G antibody titers to H. pylori in blood at patients of ischemic heart disease were measured, dependent on clinical course of disease. It was revealed that more expressed acute-phase changes in blood (leukocytosis, increased C-reactive protein contents) in the patients with unstable angina and acute myocardial infarction, as compared with appropriate parameters in stable stenocardia, were accompanied by increased titers of IgG antibodies against H. pylori.
About the Authors
A. Ye. Kratnov
Ярославская государственная медицинская академия, г. Ярославль
Russian Federation
Russian Federation
O. N. Pavlov
Ярославская государственная медицинская академия, г. Ярославль
Russian Federation
Russian Federation
References
1. Климов А.H. Иммунореактивность и атеросклероз. – Л.: Медицина, 1986.
2. Кононов А.В. Местный иммунный ответ на инфекцию Helicobacter pylori // 7-я сессия Российской группы по изучению Helicobacter pylori: Материалы. – Нижний Новгород, 1998. – С. 14-19.
3. Кремнева Л.В. Лейкоцитоз как показатель риска ИБС и ее обострений: Обзор // Терапевт. арх. – 2004. – № 11. – C. 30-35.
4. Лазебник Л.Б., Царегородцева Т.М., Серова Т.И., Соколова Г.Н., Клишина М.В., Губина А.В. Антитела к Helicobacter pylori при болезнях желудка // Терапевт. арх. – 2006. – № 2. – P. 15-19.
5. Нагорнев В.А. Атерогенез и иммунное воспаление // Арх. патологии. – 1995. – № 3. – С. 6-14.
6. Насонов Е.Л. Маркеры воспаления и атеросклероз: значение С-реактивного белка // Кардиология. – 1999. – № 2. – С. 81-85.
7. Bruins P., te Velthuis H., Yazdanbakhsh A.P. et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia // Circulation. – 1997. – Vol. 96. – P. 3542-3548.
8. Castro Cabezas M., Erkelens D.W., van Dijk H. Free fatty acids: mediators of insulin resistance and atherosclerosis // Ned. Tijdschr. Geneeskd. – 2002. – Vol. 3. – P. 103-109.
9. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina // Lancet. – 1997. – Vol. 349. – P. 462-466.
10. Highton J., Hessian P. A solid-phase enzyme immunoassay for C-reactive protein: clinical value and the effect of rheumatoid factor // J. Immunol. Methods. – 1984. – Vol. 68. – P. 185-192.
11. Libby Р., Egan D., Skarlatos S. Roles of infections agents in atherosclerosis and restenosis: аn assessment of the evidence and need for future research // Circulation. – 1997. – Vol. 96. – P. 4095-4103.
12. Mach F., Lovis C., Gaspoz J.-M., Unger P.- F., Bouillie M., Urban P., Rutishauser W. C-reactive protein as a marker for acute coronary syndrome // Eur. Heart. J. – 1997. – Vol. 9. – P. 1897-1902.
13. Migneco A., Ojetti V., Specchia L., Franceschi F., Candelli M., Mettimano M., Montebelli R., Savi L., Gasbarrini G. Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension // Helicobacter. – 2003. – Vol. 8. – P. 585-589.
14. Milloning G., Schwentner Ch., Mueller P., Mayerl C., Wick G. The vascular-associated lymphoid tissue: а new site of local immunity // Curr. Opin. Lipidol. – 2001. – Vol. 12. – P. 547-553.
15. Ridker P.M., Rifai N., Pfeffer M.A., Sacks F.M., Moye L.A., Goldman S., Flaker G.C., Braunwald E. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels // Circulation. – 1998. – Vol. 98. – P. 839-844.
Review
For citations:
Kratnov A.Ye., Pavlov O.N. C-REACTIVE PROTEIN AND ANTIBODIES TO HELICOBACTER PYLORI IN THE PATIENTS WITH ISCHEMIC HEART DISEASE. Medical Immunology (Russia). 2007;9(4-5):523-526. (In Russ.) https://doi.org/10.15789/1563-0625-2007-4-5-523-526
Views:
1454
Email this article 